Author: ipasa

Emma Knox joined GSK UK in 2004. She has held a variety of roles in Sales, Marketing and Market Access across Europe, Emerging Market and more recently in Southern Africa. She moved to South Africa in 2012 where she took on the role of Marketing and...

Erika Koppers joined Shire as Country Lead, South Africa in November 2016 to establish the legal entity and set up operations as Shire Pharmaceuticals SA. Prior to joining Shire, Erika worked at AstraZeneca and Roche covering various commercial roles with local and Sub-Sahara responsibilities across a...

Daniel Binette has been appointed Managing Director of Lilly South Africa. His career at Lilly spans 18 years where 15 were spent in Canada in various commercial roles. He is known as a strategic, dynamic, customer focused and results-oriented leader with multiple launch experiences. Before coming...

Xolani Gwala hosted the second edition of #Change4Cancer. Joining him was a panel of various stakeholders who looked at the many answered questions related to the disease. They looked at matters relating to access to quality treatment, early screening and detection, behavioural change and alternative healing methods. The...

AfricaBio, has the pleasure of announcing that the inaugural BIO Africa Convention will be opened by SA Minister of Science and Technology, Ms Mmamoloko Kubayi-Ngubane. AfricaBio is an independent non-profit stakeholders’ association, that represent stakeholders in the biotechnology sector throughout Africa, and promote the use...

Draft IP Policy - Phase I IPASA Cover Letter 171117 NHI Implementation Structure - IPASA Submission 20171130 NHI Implementation Structures - IPASA Cover Letter POPI Regulations - IPASA Comments 171107 POPI Regulations - IPASA Cover Letter Revised Draft IP Policy - IPASA Narrative Submission 171117 6 23 Comments_SAHPRA Regulations 170419 6 23...

Recently appointed the CEO of IPASA, the Innovative Pharmaceutical Association of South Africa; Konji has over 25 years’ experience in the Public and Private sector. She is a Medical Practitioner by training, with a Bachelor of Science degree from the University of the North (now...

Official MC for the IPASA Innovative Medicines Summit 2016 McLean Sibanda is an engineer and patent attorney. He has recently been appointed for a second term as the Chief Executive Officer of The Innovation Hub, a leading African Science Park. He has extensive experience in intellectual...

Innovative Reimbursement Dr Jonathan Broomberg is Chief Executive Officer of Discovery Health, South Africa's largest health insurer, which manages 19 health funds, comprising over 3.3 million members. Jonathan studied medicine at the University of the Witwatersrand, South Africa, and then read PPE at Balliol College as a...

The Global Trend Towards Personalized Medicine Michael serves as Research Director for the IMS Institute. He writes and speaks regularly on key health care topics related to the current and future place of biopharmaceuticals in healthcare. He brings a deep understanding of complex data sources and...

Opening Remarks Dr Timmy Kedijang is the current President of IPASA since 2014.  Dr Kedijang is a Medical Doctor by qualification, having graduated with a Bachelors of Medicine and Surgery (MBchB) from University of KwaZulu Natal.  Additionally he holds a Master’s of Science in Clinical Pharmacology...